Wood Tarver Financial Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37K Hold
775
0.01% 303
2025
Q1
$26.4K Hold
775
0.01% 325
2024
Q4
$30K Buy
+775
New +$30K 0.01% 313